The Street’s Key Stock Analysts Research Reports
$ADT, $ARMK, $BP, $BECN,$COG, $CTAS, $FTNT, $INGN, $OLYS, $SPY
- Barclays set a 3,000 target for the S&P 500 (SPY) for Y 2019
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of The Street’s Key analysts outlook for Key issues for Wednesday as follows:
ADT Inc. (NYSE:ADT) was started with an Outperform rating and was assigned a 12 price target at RBC Capital Markets.
Aramark (NYSE:ARMK) was started as Outperform with a 47 price target at RBC Capital Markets. Aramark has a consensus analyst target price at 47.67.
BP PLC (NYSE:BP) was raised to Outperform from Market Perform at Raymond James. BP has a 52-wk trading range of 36.15 to 47.82 and its ADSs indicated down 1% at 40.50 Tuesday.
Beacon Roofing Supply (NASDAQ:BECN) was maintained as Outperform at Wedbush Securities, but the firm slashed its target price to 30 from 50. Raymond James lowered its rating to Outperform from Strong Buy as well.
Cabot Oil & Gas Corporation (NYSE:COG) was downgraded to Neutral from Buy with a 29 target price at Goldman Sachs. Cabot Oil & Gas has a consensus analyst target price at 27.04.
Cintas Corp. (NASDAQ:CTAS) was started as Outperform with a 215 price target at RBC Capital Markets. Cintas has a consensus analyst target price at 210.78.
Fortinet, Inc. (NASDAQ FTNT) was raised to Outperform from Market Perform at Raymond James. Fortinet has a consensus analyst target price of 84.54.
Inogen, Inc. (NASDAQ:INGN) was raised to Strong Buy from Buy with a 280 price target at Needham & Co.
Qualys, Inc. (NASDAQ:QLYS) was raised to Buy from Neutral with a 100 price target at BTIG Research. Qualys has a 52-wk trading range of 55.05 – 98.30 and has a consensus analyst price target at 93.25.
To our USA subscribers and readers, have a Happy Thanksgiving Holiday!
Latest posts by HEFFX Australia (see all)
- Tesla (NASDAQ:TSLA) A Look At The Technicals - August 3, 2020
- Shimizu (1803.T) Compelling Upside Potential - August 3, 2020
- HEFFX Projects Over 30% Upside For Astellas Pharma (4503.T) - August 3, 2020